FDA 483 - Lupin Manufacturing Solutions Limited - January 17, 2020

Lupin Limited, an API manufacturer in Visakhapatnam, India, was cited with five observations during an FDA inspection in January 2020. The inspection revealed significant deficiencies in process validation, discrepancy investigations, control of reference standards, raw material sampling, and master batch record controls. These issues indicate a lack of robust quality systems for API manufacturing.